These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35641955)

  • 1. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review.
    Shen J; Begum N; Ruiz-Garcia Y; Martinon-Torres F; Bekkat-Berkani R; Meszaros K
    BMC Public Health; 2022 May; 22(1):1078. PubMed ID: 35641955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.
    Olbrich KJ; Müller D; Schumacher S; Beck E; Meszaros K; Koerber F
    Infect Dis Ther; 2018 Dec; 7(4):421-438. PubMed ID: 30267220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease.
    Scholz S; Schwarz M; Beck E; Meszaros K; Schneider M; Ultsch B; Greiner W
    Infect Dis Ther; 2022 Feb; 11(1):367-387. PubMed ID: 34877641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Sequelae of Invasive Meningococcal Disease in the United States.
    Marshall GS; McCormick ZL; Johns JS; Verduzco-Gutierrez M; Herrera-Restrepo O; Harrison LH
    Infect Dis Ther; 2024 Nov; 13(11):2213-2220. PubMed ID: 39269567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Health Burden of Invasive Meningococcal Disease: A Systematic Review.
    Strifler L; Morris SK; Dang V; Tu HA; Minhas RS; Jamieson FB; Deeks SL; Crowcroft NS; Sander B
    J Pediatric Infect Dis Soc; 2016 Dec; 5(4):417-430. PubMed ID: 26501470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.
    Guedes S; Bricout H; Langevin E; Tong S; Bertrand-Gerentes I
    BMC Public Health; 2022 Mar; 22(1):521. PubMed ID: 35296287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.
    Marten O; Koerber F; Bloom D; Bullinger M; Buysse C; Christensen H; De Wals P; Dohna-Schwake C; Henneke P; Kirchner M; Knuf M; Lawrenz B; Monteiro AL; Sevilla JP; Van de Velde N; Welte R; Wright C; Greiner W
    Health Qual Life Outcomes; 2019 May; 17(1):87. PubMed ID: 31118091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.
    Marshall H; McMillan M; Wang B; Booy R; Afzali H; Buttery J; Blyth CC; Richmond P; Shaw D; Gordon D; Barton B
    BMJ Open; 2019 Dec; 9(12):e032583. PubMed ID: 31888931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of invasive meningococcal disease and its sequelae: a population-based study in Italian primary care, 2000-2019.
    Lapi F; Marconi E; Vetrano DL; Rossi A; Lagolio E; Baldo V; Cricelli C
    Fam Pract; 2023 Jun; ():. PubMed ID: 37262015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
    Ivanova-Markova Y; González-Domínguez A; Hidalgo A; Sánchez R; García-Agua N; García-Ruiz AJ; Amanda Vallejo-Aparicio L; García A; Rodriguez R; de Gomensoro E; Gonzalez-Inchausti MDC; Shen J; Begum N; Tafalla M
    Vaccine; 2021 Dec; 39(52):7646-7654. PubMed ID: 34794819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of invasive meningococcal disease in children: SEINE study protocol.
    Baloche A; Jung C; Levy M; Elbez-Rubinstein A; Béchet S; Layouni I; Monguillot G; Taha MK; Cohen R; Levy C
    PLoS One; 2022; 17(5):e0268536. PubMed ID: 35617288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease.
    Beck E; Klint J; Neine M; Garcia S; Meszaros K
    Value Health; 2021 Jan; 24(1):91-104. PubMed ID: 33431159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of sequelae after invasive meningococcal disease.
    Voss SS; Nielsen J; Valentiner-Branth P
    BMC Infect Dis; 2022 Feb; 22(1):148. PubMed ID: 35148717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.
    Gruhn S; Witte J; Greiner W; Damm O; Dietzsch M; Kramer R; Knuf M
    Vaccine; 2022 Mar; 40(13):1932-1947. PubMed ID: 35227520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
    Weil-Olivier C; Taha MK; Bouée S; Emery C; Loncle-Provot V; Nachbaur G; Beck E; Pribil C
    Hum Vaccin Immunother; 2022 Dec; 18(1):2021764. PubMed ID: 35192785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review.
    Anonychuk A; Woo G; Vyse A; Demarteau N; Tricco AC
    Pharmacoeconomics; 2013 Jul; 31(7):563-76. PubMed ID: 23673904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM).
    Shen J; Bouée S; Aris E; Emery C; Beck EC
    Infect Dis Ther; 2022 Feb; 11(1):249-262. PubMed ID: 34791633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.
    Vespa Presa J; Abalos MG; Sini de Almeida R; Cane A
    Int J Infect Dis; 2019 Aug; 85():37-48. PubMed ID: 31085314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminans.
    Bénard S; Wright C; Voisine J; Olivier CW; Gaudelus J
    J Infect Public Health; 2016; 9(3):339-47. PubMed ID: 26688376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.